Letter: metabolic dysfunction-associated fatty liver disease increases risk of all-cause mortality in patients with chronic hepatitis C

被引：0
|
作者：
Zhao, Qianwen [1 ]
Deng, Yunlei [2 ]
机构：
[1] Sichuan Univ, Sichuan Univ Univ Oxford Huaxi Joint Ctr Gastroint, West China Hosp, Dept Gastroenterol & Hepatol, Chengdu, Peoples R China
[2] Southwest Jiaotong Univ, Peoples Hosp 3, Dept Nephrol, Affiliated Hosp, 82 Qinglong St, Chengdu 610031, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 57卷 / 02期
关键词：
D O I：
10.1111/apt.17294
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Attia et al paper. To view this article, visit
引用
收藏
页码：272 / 273
页数：2
相关论文
共 50 条
  • [1] Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
    Kim, Donghee
    Konyn, Peter
    Sandhu, Keeryth K.
    Dennis, Brittany B.
    Cheung, Amanda C.
    Ahmed, Aijaz
    JOURNAL OF HEPATOLOGY, 2021, 75 (06) : 1284 - 1291
  • [2] ASSOCIATIONS OF METABOLIC SUBTYPES OF METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE WITH RISK OF CARDIOVASCULAR MORTALITY AND ALL-CAUSE MORTALITY IN THE UNITED STATES
    Zeng, Guyu
    Wang, Peizhi
    Yuan, Jinqing
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1968 - 1968
  • [3] Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B
    van Kleef, Laurens A.
    Choi, Hannah S. J.
    Brouwer, Willem P.
    Hansen, Bettina E.
    Patel, Keyur
    de Man, Robert A.
    Janssen, Harry L. A.
    de Knegt, Robert J.
    Sonneveld, Milan J.
    JHEP REPORTS, 2021, 3 (05)
  • [4] Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality
    Oh, Rosa
    Kim, Seohyun
    Cho, So Hyun
    Kim, Jiyoon
    Lee, You-Bin
    Jin, Sang-Man
    Hur, Kyu Yeon
    Kim, Gyuri
    Kim, Jae Hyeon
    DIABETES & METABOLISM JOURNAL, 2025, 49 (01)
  • [5] Metabolic dysfunction-associated fatty liver disease subgroups and risk of hepatocellular carcinoma and mortality in patients with chronic viral hepatitis
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Ahn, Sang Hoon
    JOURNAL OF HEPATOLOGY, 2022, 77 : S100 - S100
  • [6] Are there all-cause mortality differences between metabolic dysfunction-associated steatotic liver disease subtypes?
    Li, Mengqi
    Xie, Wen
    JOURNAL OF HEPATOLOGY, 2024, 80 (02) : e53 - e54
  • [7] Nonalcoholic Fatty Liver Disease, Metabolic Dysfunction Associated Fatty Liver Disease, and Associations with All-Cause and Cause Specific Mortality
    Huang, Qi
    Zou, Xiantong
    Zhou, Xianghai
    Ji, Linong
    DIABETES, 2021, 70
  • [8] Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in Taiwan MJ cohort
    Cheng, Wei-Chun
    Chen, Hua-Fen
    Cheng, Hsiu-Chi
    Li, Chung-Yi
    EPIDEMIOLOGY AND HEALTH, 2024, 46 : e2024024
  • [9] Metabolic dysfunction-associated fatty liver disease and chronic hepatitis B
    Huang, Shang -Chin
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (11) : 2148 - 2151
  • [10] DIABETIC METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IS ASSOCIATED WITH INCREASED RISK OF HEPATOCELLULAR CARCINOMA AND MORTALITY IN CHRONIC VIRAL HEPATITIS PATIENTS
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong-Gyu
    Ahn, Sang Hoon
    HEPATOLOGY, 2022, 76 : S244 - S245
12345